Causal and Synthetic Associations of Variants in the Gene Cluster with Alpha1-antitrypsin Serum Levels

English version České info

Several infrequent genetic polymorphisms in the SERPINA1 gene are known to substantially reduce concentration of alpha1-antitrypsin (AAT) in the blood. Since low AAT serum levels fail to protect pulmonary tissue from enzymatic degradation, these polymorphisms also increase the risk for early onset chronic obstructive pulmonary disease (COPD). The role of more common SERPINA1 single nucleotide polymorphisms (SNPs) in respiratory health remains poorly understood.

We present here an agnostic investigation of genetic determinants of circulating AAT levels in a general population sample by performing a genome-wide association study (GWAS) in 1392 individuals of the SAPALDIA cohort.

Five common SNPs, defined by showing minor allele frequencies (MAFs) >5%, reached genome-wide significance, all located in the SERPINA gene cluster at 14q32.13. The top-ranking genotyped SNP rs4905179 was associated with an estimated effect of β = −0.068 g/L per minor allele (P = 1.20*10⁻¹²). But denser SERPINA1 locus genotyping in 5569 participants with subsequent stepwise conditional analysis, as well as exon-sequencing in a subsample (N = 410), suggested that AAT serum level is causally determined at this locus by rare (MAF<1%) and low-frequent (MAF 1–5%) variants only, in particular by the well-documented protein inhibitor S and Z (PI S, PI Z) variants. Replication of the association of rs4905179 with AAT serum levels in the Copenhagen City Heart Study (N = 8273) was successful (P<0.0001), as was the replication of its synthetic nature (the effect disappeared after adjusting for PI S and Z, P = 0.57). Extending the analysis to lung function revealed a more complex situation. Only in individuals with severely compromised pulmonary health (N = 397), associations of common SNPs at this locus with lung function were driven by rarer PI S or Z variants. Overall, our meta-analysis of lung function in ever-smokers does not support a functional role of common SNPs in the SERPINA gene cluster in the general population.

Vyšlo v časopise: Causal and Synthetic Associations of Variants in the Gene Cluster with Alpha1-antitrypsin Serum Levels. PLoS Genet 9(8): e32767. doi:10.1371/journal.pgen.1003585
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003585

Souhrn

Zdroje

1. BrantlyML, WittesJT, VogelmeierCF, HubbardRC, FellsGA, et al. (1991) Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes. Chest 100: 703–708.

2. LomasDA, EvansDL, FinchJT, CarrellRW (1992) The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357: 605–607.

3. LuisettiM, SeersholmN (2004) Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency. Thorax 59: 164–169.

4. LiebermanJ, WinterB, SastreA (1986) Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest 89: 370–373.

5. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med 168: 818–900.

6. HershCP, DahlM, LyNP, BerkeyCS, NordestgaardBG, et al. (2004) Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 59: 843–849.

7. DahlM, HershCP, LyNP, BerkeyCS, SilvermanEK, et al. (2005) The protease inhibitor PI*S allele and COPD: a meta-analysis. Eur Respir J 26: 67–76.

8. SorheimIC, BakkeP, GulsvikA, PillaiSG, JohannessenA, et al. (2010) alpha-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest 138: 1125–1132.

9. ThunGA, FerrarottiI, ImbodenM, RochatT, GerbaseM, et al. (2012) SERPINA1 PiZ and PiS Heterozygotes and Lung Function Decline in the SAPALDIA Cohort. PLoS One 7: e42728.

10. WilkJB, ShrineNR, LoehrLR, ZhaoJH, ManichaikulA, et al. (2012) Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med 186: 622–632.

11. ArtigasMS, LothDW, WainLV, GharibSA, ObeidatM, et al. (2011) Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 43: 1082–1090.

12. ImbodenM, BouzigonE, CurjuricI, RamasamyA, KumarA, et al. (2012) Genome-wide association study of lung function decline in adults with and without asthma. J Allergy Clin Immunol 129: 1218–1228.

13. KongX, ChoMH, AndersonW, CoxsonHO, MullerN, et al. (2011) Genome-wide Association Study Identifies BICD1 as a Susceptibility Gene for Emphysema. Am J Respir Crit Care Med 183: 43–49.

14. ObeidatM, WainLV, ShrineN, KalshekerN, ArtigasMS, et al. (2011) A comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample. PLoS One 6: e19382.

15. LawRH, ZhangQ, McGowanS, BuckleAM, SilvermanGA, et al. (2006) An overview of the serpin superfamily. Genome Biol 7: 216.

16. DicksonSP, WangK, KrantzI, HakonarsonH, GoldsteinDB (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8: e1000294.

17. MoffattMF, GutIG, DemenaisF, StrachanDP, BouzigonE, et al. (2010) A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 363: 1211–1221.

18. FrazerKA, BallingerDG, CoxDR, HindsDA, StuveLL, et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851–861.

19. A map of human genome variation from population-scale sequencing. Nature 467: 1061–1073.

20. FerrarottiI, ThunGA, ZorzettoM, OttavianiS, ImbodenM, et al. (2012) Serum levels and genotype distribution of alpha1-antitrypsin in the general population. Thorax 67: 669–674.

21. ZorzettoM, RussiE, SennO, ImbodenM, FerrarottiI, et al. (2008) SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations. Clin Chem 54: 1331–1338.

22. MiyakeK, SuzukiH, OkaH, OdaT, HaradaS (1979) Distribution of alpha 1-antitrypsin phenotypes in Japanese: description of Pi M subtypes by isoelectric focusing. Jinrui Idengaku Zasshi 24: 55–62.

23. NukiwaT, TakahashiH, BrantlyM, CourtneyM, CrystalRG (1987) alpha 1-Antitrypsin nullGranite Falls, a nonexpressing alpha 1-antitrypsin gene associated with a frameshift to stop mutation in a coding exon. J Biol Chem 262: 11999–12004.

24. GrahamA, KalshekerNA, NewtonCR, BamforthFJ, PowellSJ, et al. (1989) Molecular characterisation of three alpha-1-antitrypsin deficiency variants: proteinase inhibitor (Pi) nullcardiff (Asp256----Val); PiMmalton (Phe51----deletion) and PiI (Arg39----Cys). Hum Genet 84: 55–58.

25. HolmesMD, BrantlyML, CrystalRG (1990) Molecular analysis of the heterogeneity among the P-family of alpha-1-antitrypsin alleles. Am Rev Respir Dis 142: 1185–1192.

26. OkayamaH, BrantlyM, HolmesM, CrystalRG (1991) Characterization of the molecular basis of the alpha 1-antitrypsin F allele. Am J Hum Genet 48: 1154–1158.

27. FaberJP, PollerW, WeidingerS, KirchgesserM, SchwaabR, et al. (1994) Identification and DNA sequence analysis of 15 new alpha 1-antitrypsin variants, including two PI*Q0 alleles and one deficient PI*M allele. Am J Hum Genet 55: 1113–1121.

28. PollerW, MerkleinF, Schneider-RaspS, HaackA, FechnerH, et al. (1999) Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile). Eur J Hum Genet 7: 321–331.

29. FraAM, GooptuB, FerrarottiI, MirandaE, ScabiniR, et al. (2012) Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization. PLoS One 7: e38405.

30. GibsonG (2011) Rare and common variants: twenty arguments. Nat Rev Genet 13: 135–145.

31. SannaS, LiB, MulasA, SidoreC, KangHM, et al. (2011) Fine mapping of five Loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability. PLoS Genet 7: e1002198.

32. OosterveerDM, VersmissenJ, DefescheJC, SivapalaratnamS, YazdanpanahM, et al. (2013) Low-density lipoprotein receptor mutations generate synthetic genome-wide associations. Eur J Hum Genet 21: 563–566.

33. GalarneauG, PalmerCD, SankaranVG, OrkinSH, HirschhornJN, et al. (2010) Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet 42: 1049–1051.

34. RivasMA, BeaudoinM, GardetA, StevensC, SharmaY, et al. (2011) Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 43: 1066–1073.

35. JohansenCT, WangJ, LanktreeMB, CaoH, McIntyreAD, et al. (2010) Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 42: 684–687.

36. CoassinS, SchweigerM, Kloss-BrandstatterA, LaminaC, HaunM, et al. (2010) Investigation and functional characterization of rare genetic variants in the adipose triglyceride lipase in a large healthy working population. PLoS Genet 6: e1001239.

37. KronenbergF, UtermannG (2013) Lipoprotein(a): resurrected by genetics. J Intern Med 273: 6–30.

38. LinJP, SchwaigerJP, CupplesLA, O'DonnellCJ, ZhengG, et al. (2009) Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels–the Framingham Heart Study. Atherosclerosis 206: 228–233.

39. HeidIM, WagnerSA, GohlkeH, IglsederB, MuellerJC, et al. (2006) Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55: 375–384.

40. AulchenkoYS, RipattiS, LindqvistI, BoomsmaD, HeidIM, et al. (2009) Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 41: 47–55.

41. ChappellS, DalyL, MorganK, Guetta BaranesT, RocaJ, et al. (2006) Cryptic haplotypes of SERPINA1 confer susceptibility to chronic obstructive pulmonary disease. Hum Mutat 27: 103–109.

42. SilvermanEK, ProvinceMA, RaoDC, PierceJA, CampbellEJ (1990) A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes. Am Rev Respir Dis 142: 1015–1021.

43. SennO, RussiEW, SchindlerC, ImbodenM, von EckardsteinA, et al. (2008) Circulating alpha1-antitrypsin in the general population: determinants and association with lung function. Respir Res 9: 35.

44. EmilssonV, ThorleifssonG, ZhangB, LeonardsonAS, ZinkF, et al. (2008) Genetics of gene expression and its effect on disease. Nature 452: 423–428.

45. HaoK, BosseY, NickleDC, ParePD, PostmaDS, et al. (2012) Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet 8: e1003029.

46. InouyeM, RipattiS, KettunenJ, LyytikainenLP, OksalaN, et al. (2012) Novel Loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet 8: e1002907.

47. LappalainenT, MontgomerySB, NicaAC, DermitzakisET (2011) Epistatic selection between coding and regulatory variation in human evolution and disease. Am J Hum Genet 89: 459–463.

48. QiuW, BaccarelliA, CareyVJ, BoutaouiN, BachermanH, et al. (2012) Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 185: 373–381.

49. Lango AllenH, EstradaK, LettreG, BerndtSI, WeedonMN, et al. (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467: 832–838.

50. TrynkaG, HuntKA, BockettNA, RomanosJ, MistryV, et al. (2011) Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 43: 1193–1201.

51. RolliniP, FournierRE (1999) The HNF-4/HNF-1alpha transactivation cascade regulates gene activity and chromatin structure of the human serine protease inhibitor gene cluster at 14q32.1. Proc Natl Acad Sci USA 96: 10308–10313.

52. MartinBW, Ackermann-LiebrichU, LeuenbergerP, KunzliN, StutzEZ, et al. (1997) SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed 42: 67–84.

53. Ackermann-LiebrichU, Kuna-DibbertB, Probst-HenschNM, SchindlerC, Felber DietrichD, et al. (2005) Follow-up of the Swiss Cohort Study on Air Pollution and Lung Diseases in Adults (SAPALDIA 2) 1991–2003: methods and characterization of participants. Soz Praventivmed 50: 245–263.

54. DahlM, Tybjaerg-HansenA, LangeP, VestboJ, NordestgaardBG (2002) Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population. Ann Intern Med 136: 270–279.

55. SandfordAJ, ChaganiT, WeirTD, ConnettJE, AnthonisenNR, et al. (2001) Susceptibility genes for rapid decline of lung function in the Lung Health Study. American Journal of Respiratory and Critical Care Medicine 163: 469–473.

56. LiY, WillerCJ, DingJ, ScheetP, AbecasisGR (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34: 816–834.

57. CarterKW, McCaskiePA, PalmerLJ (2006) JLIN: a java based linkage disequilibrium plotter. BMC Bioinformatics 7: 60.

58. BarrettJC, FryB, MallerJ, DalyMJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263–265.

59. HemmingerBM, SaelimB, SullivanPF (2006) TAMAL: an integrated approach to choosing SNPs for genetic studies of human complex traits. Bioinformatics 22: 626–627.

60. ChappellS, HadzicN, StockleyR, Guetta-BaranesT, MorganK, et al. (2008) A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease. Hepatology 47: 127–132.

61. GorriniM, FerrarottiI, LupiA, BosoniT, MazzolaP, et al. (2006) Validation of a rapid, simple method to measure alpha1-antitrypsin in human dried blood spots. Clin Chem 52: 899–901.

62. AulchenkoYS, StruchalinMV, van DuijnCM (2010) ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics 11: 134.

63. PriceAL, PattersonNJ, PlengeRM, WeinblattME, ShadickNA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38: 904–909.

64. HeathSC, GutIG, BrennanP, McKayJD, BenckoV, et al. (2008) Investigation of the fine structure of European populations with applications to disease association studies. Eur J Hum Genet 16: 1413–1429.

65. LiJ, JiL (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb) 95: 221–227.

66. PruimRJ, WelchRP, SannaS, TeslovichTM, ChinesPS, et al. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics 26: 2336–2337.

67. JohnsonAD, HandsakerRE, PulitSL, NizzariMM, O'DonnellCJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938–2939.

68. KumarP, HenikoffS, NgPC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4: 1073–1081.